Clinical Trials Directory

Trials / Unknown

UnknownNCT04452487

Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments (COVID-19-LAT)

Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments

Status
Unknown
Phase
Study type
Observational
Enrollment
2,500 (estimated)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This survey is performed to examine if during the Covid's crisis, the practitionner's have respected the modalities of the law about the end of life, in particular concerning limitations and stop of therapeutics

Detailed description

In the current legislativ context notably the Clayes Leonetti law, a very large majority of ICU (Intensive Care Unit) patients die with the establishement of a procedure for the limitation and cessation of therapeutics (LAT). During a viral pandemic, medical resources can be saturated, limiting reflexive abilities in favour of binary decisions. This sorting of patients leads to LAT that could be performed without the elementary modalities stated by the law. Thus, arbitrary medical decisions made alone could expose patients to unjustified " loss of luck ". Increasing the resources mobilized during a pandemic must not make us forget the quality of care provided for the benefit of quantity. In therefore seems legitimate to keep the LAT modalities to ensure our ethical principles. No work in the literature based on actual facts explores the impact of a pandemic on compliance with and maintenance of ethical principles and the legisltaive framework, in particular as regards the procedures of the application of LAT. The purpose of this study is to assess whether the terms of the LAT are being complied during a pandemic for patients with or without Covid.

Conditions

Interventions

TypeNameDescription
BEHAVIORALdecisions of limitations and stop processingCompliance of the modalities of decisions of limitations and stop processing

Timeline

Start date
2020-06-01
Primary completion
2021-06-01
Completion
2021-06-01
First posted
2020-06-30
Last updated
2020-06-30

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04452487. Inclusion in this directory is not an endorsement.